Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ISOX | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.7 |
mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.7 |
mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | -0.024 | 0.7 |
mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.7 |
mRNA | ML311 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.021 | 0.7 |